for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cosmos Pharmaceutical Corp

3349.T

Latest Trade

23,890.00JPY

Change

-410.00(-1.69%)

Volume

57,200

Today's Range

23,830.00

 - 

24,350.00

52 Week Range

16,850.00

 - 

25,230.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Cosmos Pharmaceutical says change of president

May 15 (Reuters) - Cosmos Pharmaceutical Corp <3349.T>:Says it appoints Hideaki Yokoyama as president, to succeed Futoshi Shibata, effective June 1 .

Limited company buys 5.3 pct stake in Cosmos Pharmaceutical

Jan 31 (Reuters) - Cosmos Pharmaceutical Corp <3349.T>:Says a limited company buys 5.3 percent stake (1 million shares) in Cosmos Pharmaceutical, with undisclosed price, on Jan. 31 .

COSMOS Pharmaceutical says change of chairman and president

May 23 (Reuters) - COSMOS Pharmaceutical Corp <3349.T> ::* Says it appoints current president Masateru Uno as new chairman, and Futoshi Shijbata as new president, effective on Aug. 25.

COSMOS Pharmaceutical to issue year-end dividend for FY 2015

COSMOS Pharmaceutical Corp:To issue a year-end dividend of 32.5 yen per share to all the shareholders of record as of May 31, for the fiscal year ended May 2015.Payment date Aug. 24.Says the dividend is above latest forecast of 27.5 yen per share.

COSMOS Pharmaceutical Corp to issue year-end dividend for FY 2014

COSMOS Pharmaceutical Corp:To issue a year-end dividend of 30 yen per share to all the shareholders of record as of May 31, for FY ended May 2014.Payment date Aug. 25.Says latest dividend forecast was 25 yen per share.

COSMOS Pharmaceutical Corp Raises Year-end Dividend Forecast for FY 2013

COSMOS Pharmaceutical Corp announced that it has raised its year-end dividend forecast from JPY 20.00 per share, which was announced on July 13, 2012, to JPY 30.00 per share, for the fiscal year ending May 2013.

COSMOS Pharmaceutical Corp Announces Changes in Shareholding Structure

COSMOS Pharmaceutical Corp announced that its current top shareholder, President of the Company, will become the sixth major shareholder of the Company with 3.03% stake, down from 23.47%, its current second major shareholder, an individual, will become the major shareholder of the Company with 3.03% stake, down from 10.61%, while a Fukuoka-based company engaged in the trading, management and operation of investment securities, will become the top shareholder of the Company with 33.08% voting rights, up from 5.05%, effective September 3, 2012.

COSMOS Pharmaceutical Corporation Announces Year-end Dividend Payment for FY 2012

COSMOS Pharmaceutical Corporation announced that it has decided to pay a year-end dividend of JPY 22.00 per share, above the last forecast of JPY 18.00 per share, to all shareholders of record as of May 31, 2012, for the fiscal year ended May 31, 2012. The payment will be conducted on August 27, 2012.

COSMOS Pharmaceutical Corporation Raises FY 2012 Outlook

COSMOS Pharmaceutical Corporation announced that it has raised its consolidated mid-year outlook for revenue from JPY 128,950 million to JPY 133,615 million, operating profit from JPY 4,920 million to JPY 6,854 million, ordinary profit from JPY 5,400 million to JPY 7,369 million, net profit from JPY 2,850 million to JPY 3,991 million and earning per share from JPY 143.94 to JPY 201.60 for the fiscal year ending May 31, 2012. The Company also raised its consolidated full-year outlook for revenue from JPY 263,500 million to JPY 268,100 million, operating profit from JPY 10,100 million to JPY 12,000 million, ordinary profit from JPY 11,100 million to JPY 13,000 million, net profit from JPY 5,890 million to JPY 6,809 million and earning per share from JPY 297.48 to JPY 343.89 for the same fiscal year. This is due to the low prices of products. According to I/B/E/S Estimates, analysts on average are expecting the Company to report full-year revenue of JPY 268.50 billion and net profit of JPY 6.73 billion.

COSMOS Pharmaceutical Corporation Raises Consolidated Full-year Outlook for FY 2011

COSMOS Pharmaceutical Corporation announced that it has raised its consolidated full-year outlook for revenue of JPY 225,000 million to JPY 237,174 million, operating profit from JPY 7,600 million to JPY 10,000 million, ordinary profit from JPY 8,400 million to JPY 11,000 million, net profit from JPY 4,170 million to JPY 5,700 million and earning per share from JPY 210.61 to JPY 287.88, for the fiscal year ended May 2011. The Company raised the outlook due to the increased sales and the cost reduction. According to I/B/E/S Estimates, analysts were expecting the Company to report full-year revenue of JPY 236.72 billion and EPS of JPY 280.77.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up